Utilization of Autologous Hematopoietic Cell Transplantation Over Time in Multiple Myeloma: A Population-Based StudyNaseem Esteghamat, Theresa H.M. Keegan, Julianne J.P. Cooley et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 8
Combination of Glofitamab with Pirtobrutinib in BTK Inhibitor (BTKi)-Naive or Btki-Intolerant Patients with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL): A Multicenter Phase 2 Study of the University of California Hematologic Malignancies ConsortiumMadhav Seshadri, Charalambos Andreadis, Lawrence D. Kaplan et al.|Blood|2024Cited by 1
Utilization of Autologous HCT in Multiple Myeloma: A Novel Linkage of CIBMTR, Cancer Registry and Hospitalization Data in CaliforniaNaseem Esteghamat, Theresa H.M. Keegan, Ann Brunson et al.|Blood|2022Cited by 0